{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T12:18:09Z","timestamp":1775909889918,"version":"3.50.1"},"reference-count":43,"publisher":"Japanese Society of Veterinary Science","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Vet. Med. Sci.","The Journal of Veterinary Medical Science"],"published-print":{"date-parts":[[2010]]},"DOI":"10.1292\/jvms.09-0281","type":"journal-article","created":{"date-parts":[[2010,3,3]],"date-time":"2010-03-03T06:03:21Z","timestamp":1267596201000},"page":"131-140","source":"Crossref","is-referenced-by-count":8,"title":["Cultivation and Characterization of Canine Skin-Derived Mast Cells"],"prefix":"10.1292","volume":"72","author":[{"given":"Shinpei","family":"KAWARAI","sequence":"first","affiliation":[{"name":"First Department of Veterinary Microbiology, School of Veterinary Medicine, Azabu University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"MASUDA","sequence":"additional","affiliation":[{"name":"Animal Allergy Clinical Laboratories"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keitaro","family":"OHMORI","sequence":"additional","affiliation":[{"name":"Laboratory of Veterinary Molecular Pathology and Therapeutics, Division of Animal Life Science, Graduate School, Institute of Symbiotic Science and Technology, Tokyo University of Agriculture and Technology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinobu","family":"MATSUURA","sequence":"additional","affiliation":[{"name":"Moores UCSD Cancer Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobutaka","family":"YASUDA","sequence":"additional","affiliation":[{"name":"Animal Allergy Clinical Laboratories"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiko","family":"NAGATA","sequence":"additional","affiliation":[{"name":"Animal Dermatology Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"SAKAGUCHI","sequence":"additional","affiliation":[{"name":"First Department of Veterinary Microbiology, School of Veterinary Medicine, Azabu University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hajime","family":"TSUJIMOTO","sequence":"additional","affiliation":[{"name":"Department of Veterinary Internal Medicine, Graduate School of Agricultural and Life Sciences, The University of Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"122","reference":[{"key":"1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2007.12.053"},{"key":"2","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(01)00157-1"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Bischoff, S. C., Schwengberg, S., Raab, R. and Manns, M. P. 1997. Functional properties of human intestinal mast cells cultured in a new culture system: enhancement of IgE receptor-dependent mediator release and response to stem cell factor. J. Immunol. 159: 5560-5567.","DOI":"10.4049\/jimmunol.159.11.5560"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Bonkobara, M., Miyake, F., Yagihara, H., Yamada, O., Azakami, D., Washizu, T., Cruz Jr., P.D. and Ariizumi, K. 2005. Canine epidermal Langerhans cells express &alpha; and &gamma; but not &beta; chains of high-affinity IgE receptor. Vet. Res. Commun. 29: 499-505.","DOI":"10.1007\/s11259-005-2494-7"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Braz&iacute;s, P., de Mora, F., Ferrer, L. and Puigdemont, A. 2002. IgE enhances Fc&epsilon;RI expression and IgE-dependent TNF-&alpha; release from canine skin mast cells. Vet. Immunol. Immunopathol. 85: 205-212.","DOI":"10.1016\/S0165-2427(01)00428-7"},{"key":"6","unstructured":"6. Braz&iacute;s, P., Queralt, M., de Mora, F., Ferrer, L. I. and Puigdemont, A. 1998. Comparative study of histamine release from skin mast cells dispersed from atopic, ascaris-sensitive and healthy dogs. Vet. Immunol. Immunopathol. 66: 43-51."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. de Mora, F., Garcia, G., Ferrer, L. and Arboix, M. 1993. Canine cutaneous mast cells dispersion and histamine secretory characterization. Vet. Immunol. Immunopathol. 39: 421-429.","DOI":"10.1016\/0165-2427(93)90072-C"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. de Mora, F., Puigdemont, A. and Torres, R. 2006. The role of mast cells in atopy: what can we learn from canine models? A thorough review of the biology of mast cells in canine and human systems. Br. J. Dermatol. 155: 1109-1123.","DOI":"10.1111\/j.1365-2133.2006.07494.x"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Foster, A. P., Littlewood, J. D., Webb, P., Wood, J. L., Rogers, K. and Shaw, S. E. 2003. Comparison of intradermal and serum testing for allergen-specific IgE using a Fc&epsilon;RI&alpha;-based assay in atopic dogs in the UK. Vet. Immunol. Immunopathol. 93: 51-60.","DOI":"10.1016\/S0165-2427(03)00052-7"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Galli, S. J. 1990. New insights into \"the riddle of the mast cells\": microenvironmental regulation of mast cell development and phenotypic heterogeneity. Lab. Invest. 62: 5-33.","DOI":"10.1007\/978-1-4612-0485-5_5"},{"issue":"3","key":"11","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2460\/ajvr.1997.58.03.293","volume":"58","year":"1997","journal-title":"Am. J. Vet. Res.","ISSN":"https:\/\/id.crossref.org\/issn\/0002-9645","issn-type":"print"},{"key":"12","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-2427(97)00166-9"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Halliwell, R. E. W. 1973. The localization of IgE in canine skin: an immunofluorescent study. J. Immunol. 110: 422-430.","DOI":"10.4049\/jimmunol.110.2.422"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Hill, P. B. and Olivry, T. 2001. The ACVD task force on canine atopic dermatitis (V): biology and role of inflammatory cells in cutaneous allergic reactions. Vet. Immunol. Immunopathol. 81: 187-198.","DOI":"10.1016\/S0165-2427(01)00310-5"},{"key":"15","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.83.12.4464"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Jensen, B. M., Akin, C. and Gilfillan, A. M. 2008. Pharmacological targeting of the KIT growth factor receptor: a therapeutic consideration for mast cell disorders. Br. J. Pharmacol. 154: 1572-1582.","DOI":"10.1038\/bjp.2008.204"},{"key":"17","doi-asserted-by":"publisher","DOI":"10.1038\/ni.f.216"},{"key":"18","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.7.2045"},{"key":"19","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-1759(00)00174-5"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Kirshenbaum, A. S., Kessler, S. W., Goff, J. P. and Metcalfe, D. D. 1991. Demonstration of the origin of human mast cells from CD34<sup>+<\/sup> bone marrow progenitor cells. J. Immunol. 146: 1410-1415.","DOI":"10.4049\/jimmunol.146.5.1410"},{"key":"21","doi-asserted-by":"publisher","DOI":"10.1007\/s004180050274"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Liao, A. T., Chien, M. B., Shenoy, N., Mendel, D. B., McMahon, G., Cherrington, J. M. and London, C. A. 2002. Inhibition of constitutively active forms of mutant kit by multitargeted indolinone tyrosine kinase inhibitors. Blood 100: 585-593.","DOI":"10.1182\/blood-2001-12-0350"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Lin, T. Y., Rush, L. J. and London, C. A. 2006. Generation and characterization of bone marrow-derived cultured canine mast cells. Vet. Immunol. Immunopathol. 113: 37-52.","DOI":"10.1016\/j.vetimm.2006.03.024"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Lin, T. Y., Thomas, R., Tsai, P. C., Breen, M. and London, C. A. 2009. Generation and characterization of novel canine malignant mast cell line CL1. Vet. Immunol. Immunopathol. 127: 114-124.","DOI":"10.1016\/j.vetimm.2008.09.027"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Luskov&aacute;, P. and Dr&aacute;ber, P. 2004. Modulation of the Fc epsilon receptor I signaling by tyrosine kinase inhibitors: search for therapeutic targets of inflammatory and allergy diseases. Curr. Pharm. Des. 10: 1727-1737.","DOI":"10.2174\/1381612043384538"},{"key":"26","doi-asserted-by":"publisher","DOI":"10.1084\/jem.174.1.7"},{"key":"27","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200838642"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Nimmo-Wilkie, J. S., Yager, J. A., Eyre, P. and Parker, W. M. 1990. Morphometric analyses of the skin of dogs with atopic dermatitis and correlations with cutaneous and plasma histamine and total serum IgE. Vet. Pathol. 27: 179-186.","DOI":"10.1177\/030098589002700305"},{"key":"29","doi-asserted-by":"publisher","DOI":"10.1101\/gad.3.6.816"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Ohmori, K., Kawarai, S., Yasuda, N., Tanaka, A., Matsuda, H., Nishimura, R., Sasaki, N., Tsujimoto, H. and Masuda, K. 2008. Identification of <i>c-kit<\/i> mutations-independent neoplastic cell proliferation of canine mast cells. Vet. Immunol. Immunopathol. 126: 43-53.","DOI":"10.1016\/j.vetimm.2008.06.014"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Ozaki, K., Yamagami, T., Nomura, K. and Narama, I. 2002. Mast cell tumors of the gastrointestinal tract in 39 dogs. Vet. Pathol. 39: 557-564.","DOI":"10.1354\/vp.39-5-557"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Pucheu-Haston, C. M., Jackson, H. A., Olivry, T., Dunston, S. M. and Hammerberg, B. 2008. Epicutaneous sensitization with <i>Dermatophagoides farinae<\/i> induces generalized allergic dermatitis and elevated mite-specific immunoglobulin E levels in a canine model of atopic dermatitis. Clin. Exp. Allergy 38: 667-679.","DOI":"10.1111\/j.1365-2222.2008.02949.x"},{"key":"33","doi-asserted-by":"publisher","DOI":"10.1007\/s000110050007"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Riedy, M. C., Muirhead, K. A., Jensen, C. P. and Stewart, C. C. 1991. Use of a photo labeling technique to identify nonviable cells in fixed homologous or heterologous cell populations. Cytometry 12: 133-139.","DOI":"10.1002\/cyto.990120206"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Rottem, M., Okada, T., Goff, J. P. and Metcalfe, D. D. 1994. Mast cells cultured from the peripheral blood of normal donors and patients with mastocytosis originate from a CD34+\/Fc epsilon RI- cell population. Blood 15: 2489-2496.","DOI":"10.1182\/blood.V84.8.2489.bloodjournal8482489"},{"key":"36","unstructured":"36. Saito, H., Ebisawa, M., Tachimoto, H., Shichijo, M., Fukagawa, K., Matsumoto, K., Iikura, Y., Awaji, T., Tsujimoto, G., Yanagida, M., Uzumaki, H., Takahashi, G., Tsuji, K. and Nakahata, T. 1996. Selective growth of human mast cells induced by Steel factor, IL-6, and prostaglandin E2 from cord blood mononuclear cells. J. Immunol. 157: 343-350."},{"key":"37","unstructured":"37. Shimizu, Y., Sakai, K., Miura, T., Narita, T., Tsukagoshi, H., Satoh, Y., Ishikawa, S., Morishita, Y., Takai, S., Miyazaki, M., Mori, M., Saito, H., Xia, H. and Schwartz, L. B. 2002. Characterization of `adult-type' mast cells derived from human bone marrow CD34(+) cells cultured in the presence of stem cell factor and interleukin-6. Interleukin-4 is not required for constitutive expression of CD54, Fc epsilon RI alpha and chymase, and CD13 expression is reduced during differentiation. Clin. Exp. Allergy 32: 872-880."},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Strunk, R. C. and Bloomberg, G. R. 2006. Omalizumab for asthma. N. Engl. J. Med. 22: 2689-2695.","DOI":"10.1056\/NEJMct055184"},{"key":"39","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2008.03.033"},{"key":"40","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.88.14.6382"},{"key":"41","doi-asserted-by":"publisher","DOI":"10.1084\/jem.174.1.125"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Wershil, B. K., Wang, Z. S., Gordon, J. R. and Galli, S. J. 1991. Recruitment of neutrophils during IgE-dependent cutaneous late phase reactions in the mouse is mast cell-dependent. Partial inhibition of the reaction with antiserum against tumor necrosis factor-alpha. J. Clin. Invest. 87: 446-453.","DOI":"10.1172\/JCI115016"},{"key":"43","doi-asserted-by":"publisher","DOI":"10.1292\/jvms.62.1223"}],"container-title":["Journal of Veterinary Medical Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/jvms\/72\/2\/72_09-0281\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,24]],"date-time":"2024-03-24T15:29:17Z","timestamp":1711294157000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/jvms\/72\/2\/72_09-0281\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1292\/jvms.09-0281","relation":{},"ISSN":["0916-7250","1347-7439"],"issn-type":[{"value":"0916-7250","type":"print"},{"value":"1347-7439","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010]]}}}